| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
18,453 | 20,757 | 19,097 | 25,933 | 28,383 |
|
Cost of Revenue
|
-22,293 | -22,926 | -23,539 | -25,390 | -32,992 |
|
Gross Profit
|
-3,840 | -2,169 | -4,442 | 543 | -4,609 |
| Selling, General and Administrative Expenses
|
-10,636 | -10,183 | -10,370 | -11,978 | -20,066 |
|
Research and Development Expenses
|
-340 | -340 | -278 | -1,685 | -1,256 |
| Provision Expense/Write-Back
|
0 | 0 | -3,691 | -3,794 | 0 |
| Other Income/Expense, Operating
|
-1,742 | -1,742 | -2,149 | -6,680 | -4,047 |
|
Operating Income/Expenses
|
-12,718 | -12,265 | -16,488 | -24,137 | -25,369 |
|
Total Operating Profit/Loss
|
-16,558 | -14,434 | -20,930 | -23,594 | -29,978 |
| Total Net Finance Income/Expense
|
-205 | -215 | 57 | 736 | 503 |
| Net Investment Income
|
-3,307 | -803 | 219 | -4,985 | -908 |
| Irregular Income/Expenses
|
-10,763 | -12,047 | -33,262 | -46,728 | -13,872 |
|
Other Income/Expense, Non-Operating
|
8 | 11 | 218 | 532 | 1,518 |
|
Non-Operating Income/Expenses, Total
|
-14,267 | -13,054 | -32,768 | -50,445 | -12,759 |
|
Pretax Income
|
-30,825 | -27,488 | -53,698 | -74,039 | -42,737 |
|
Provision for Income Tax
|
-67 | 0 | -8 | -4 | -172 |
|
Net Income from Continuing Operations
|
-30,892 | -27,488 | -53,706 | -74,043 | -42,909 |
|
Discontinued Operations
|
0 | -- | 0 | -3,481 | -26,752 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-30,892 | -27,488 | -53,706 | -77,524 | -69,661 |
|
Non-Controlling/Minority Interests
|
3,459 | 3,559 | 6,810 | 16,897 | 9,821 |
|
Net Income after Non-Controlling/Minority Interests
|
-27,433 | -23,929 | -46,896 | -60,627 | -59,840 |
|
Net Income Available to Common Stockholders
|
-27,433 | -23,929 | -46,896 | -60,627 | -59,840 |
|
Diluted Net Income Available to Common Stockholders
|
-27,433 | -23,929 | -46,896 | -60,627 | -59,840 |
| Basic EPS
|
-2.94 | -2.66 | -6.63 | -8.67 | -10.72 |
| Diluted EPS
|
-2.94 | -2.66 | -6.63 | -8.67 | -10.72 |
|
Basic Weighted Average Shares Outstanding
|
9,470.4220 | 8,991.4250 | 7,072.3770 | 6,996.3220 | 5,581.1060 |
|
Diluted Weighted Average Shares Outstanding
|
9,470.4220 | 8,991.4250 | 7,702.3770 | 6,996.3220 | 5,581.1060 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-30,620 | -27,273 | -53,755 | -74,775 | -43,240 |
|
EBITDA
|
-26,870 | -23,743 | -50,771 | -69,569 | -31,067 |
12/31/2022 - 4/8/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade